Jump to content

Drilldown: Medicines

Choose a table:


Medicines > fda max : Not yet approved or Titrated to glucose; no fixed maximum & duration: Daily dosing

Use the filters below to narrow your results.

generic:
None (1)
brand:
REL-1017 / esmethadone (investigational; not yet FDA-approved as of mid-2024) (1)
classes:
low-trapping) (1) · NMDA receptor antagonist (uncompetitive (1)
mechanism:
None (1)
uses:
Investigational for major depressive disorder; trials underway (phase 3 mixed results) (1)
starting dose:
Trials use 25 mg or 50 mg PO daily (1)
preparations:
Investigational oral capsule (1)
fda max: (Click arrow to add another value)
routes:
Oral (1)
onset:
Rapid (within 1 week in trials) (1)
duration: (Click arrow to add another value)
halflife:
Not formally established (1)
bioavailability:
Oral bioavailability suitable for daily dosing (1)
pregnancy:
Investigational (1)
legal:
Investigational (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"